News Detail
Chennai, 26 Oct 2023: As India has obviously become the manufacturing hub of pharmaceuticals for the medicinal requirements of the world population, it is necessary for the Indian companies to raise the standards of manufacturing processes to the global level, observes Drug Contr......
View Details
Source : Pharmabiz
manufacturing hub
DCGI
Dr. Rajivsingh Raghuvanshi
cGMP
CDSCO
Schedule M
quality assurance
NSQs
Not-of-Standard-Qualities
Indian Pharmacopoeia
WHO
US FDA
softgel
Pharmexcil
TN IDMA
Sangrose Laboratories
Related News
- 1900 packings of fake Fair and Glow, Ponds Cream recovered (08-12-2023)
- India plans a digital Drug Regulatory System (08-12-2023)
- First Acute Kidney Injury Diagnostic Test Wins FDA Clearance (08-12-2023)
- Indian pharma companies recorded 9 percent 5-year CAGR (08-12-2023)
- Two crore alcoholic herbal syrup bottles sold across Saurashtra since 2023 (08-12-2023)
- Telangana DCA tightens noose against spurious drug manufacturers following seizure of spurious cancer drugs (08-12-2023)
- US FDA India & DIA India to host series of workshops on generic drug life-cycle management (08-12-2023)
- Gujarat: 8 arrested for manufacture, sale of beer in guise of Ayurvedic syrup (08-12-2023)
- WHO: More contaminated medicinal syrups found in new regions, including Southeast Asia (08-12-2023)
- IPC issues alert for painkiller mefenamic acid (08-12-2023)